Trial intelligence / Profile preview

Single-center randomized placebo-controlled trial of theophylline for nephroprotection during cisplatin chemotherapy

2005-004540-31Phase 2Terminated

Sponsor
University Hospital Tübingen
Start
Sep 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial in Non-hematologic malignancy and hematopoietic malignancies comparing Theophylline arm with Placebo arm (2 arms). Started Sep 2006; status: terminated.

02

Drugs

theophylline
03

Conditions

Non-hematologic malignancyhematopoietic malignancies

Beyond the preview

Go deeper on 2005-004540-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-004540-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call